Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-14

Clinical Trial Update: Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for azelnidipine in hypertensive patients with coronary atherosclerosis using serial volumetric IVUS analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelnidipine (Azelnidipine)

Snippet

Sponsor: Juntendo University | Conditions: Hypertension, Coronary Atherosclerosis | Phase 4 | Status: COMPLETED